Clinical Trial Update: A Study to Evaluate the Antiviral Effect, Safety and Tolerability of GSK3810109A in Viremic Human Immunodeficiency Virus (HIV)-1 Infected Adults [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating antiviral effect, safety and tolerability of GSK3810109A in viremic HIV-1 infected adults has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• GSK3810109A

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2023-11-18